Literature DB >> 28450075

Congenital Adrenal Hyperplasia.

Selma Feldman Witchel1.   

Abstract

The congenital adrenal hyperplasias comprise a family of autosomal recessive disorders that disrupt adrenal steroidogenesis. The most common form is due to 21-hydroxylase deficiency associated with mutations in the 21-hydroxylase gene, which is located at chromosome 6p21. The clinical features associated with each disorder of adrenal steroidogenesis represent a clinical spectrum that reflect the consequences of the specific mutations. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and preservation of fertility. For adolescent and adult men, prevention and early treatment of testicular adrenal rest tumors is beneficial. In this article key aspects regarding pathophysiology, diagnosis, and treatment of congenital adrenal hyperplasia are reviewed.
Copyright © 2017 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ambiguous genitalia; CYP21A2; Congenital adrenal hyperplasia; Hyperandrogenism; Premature adrenarche; Premature pubarche

Mesh:

Substances:

Year:  2017        PMID: 28450075      PMCID: PMC5624825          DOI: 10.1016/j.jpag.2017.04.001

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  172 in total

1.  Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency.

Authors:  A Belgorosky; S Chahin; M A Rivarola
Journal:  Acta Paediatr       Date:  1996-10       Impact factor: 2.299

2.  Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis.

Authors:  S F Witchel; S Nayak; M Suda-Hartman; P A Lee
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

3.  Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

Authors:  W K McGee; C V Bishop; A Bahar; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Hum Reprod       Date:  2011-11-23       Impact factor: 6.918

4.  A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.

Authors:  P W Speiser; E S Knochenhauer; D Dewailly; F Fruzzetti; J A Marcondes; R Azziz
Journal:  Mol Genet Metab       Date:  2000-11       Impact factor: 4.797

5.  A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

Authors:  Héctor F Escobar-Morreale; Raul Sanchón; José L San Millán
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

6.  Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

Authors:  J H Levin; E Carmina; R A Lobo
Journal:  Fertil Steril       Date:  1991-10       Impact factor: 7.329

Review 7.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

8.  Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children.

Authors:  Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf
Journal:  J Clin Endocrinol Metab       Date:  2010-01-26       Impact factor: 5.958

9.  Characterization of the molecular genetic pathology in patients with 11β-hydroxylase deficiency.

Authors:  Christiaan F Mooij; Silvia Parajes; Ian T Rose; Angela E Taylor; Taner Bayraktaroglu; John A H Wass; John M C Connell; David W Ray; Wiebke Arlt; Nils Krone
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-14       Impact factor: 3.478

10.  Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.

Authors:  Nils Krone; Ian T Rose; Debbie S Willis; James Hodson; Sarah H Wild; Emma J Doherty; Stefanie Hahner; Silvia Parajes; Roland H Stimson; Thang S Han; Paul V Carroll; Gerry S Conway; Brian R Walker; Fiona MacDonald; Richard J Ross; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

View more
  19 in total

1.  Congenital Adrenal Hyperplasia and Brain Health: A Systematic Review of Structural, Functional, and Diffusion Magnetic Resonance Imaging (MRI) Investigations.

Authors:  Noor Khalifeh; Adam Omary; Devyn L Cotter; Mimi S Kim; Mitchell E Geffner; Megan M Herting
Journal:  J Child Neurol       Date:  2022-06-23       Impact factor: 2.363

2.  Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.

Authors:  Sara Costa; Lurdes Sampaio; Ana Berta Sousa; Chao Xing; Anil K Agarwal; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

3.  Clinicoradiologic diagnosis of a rare type of congenital adrenal hyperplasia: A case report from Nepal.

Authors:  Hensan Khadka; Siddhartha Bhandari; Prakash Dhakal; Suraj Sharma
Journal:  Clin Case Rep       Date:  2022-06-09

Review 4.  Update on adrenarche.

Authors:  Selma Feldman Witchel; Bianca Pinto; Anne Claire Burghard; Sharon E Oberfield
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

5.  The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both.

Authors:  Yinjie Gao; Bingqing Yu; Jiangfeng Mao; Xi Wang; Min Nie; Xueyan Wu
Journal:  Endocrine       Date:  2019-10-11       Impact factor: 3.633

6.  A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia.

Authors:  Violeta Anastasovska; Mirjana Kocova; Nikolina Zdraveska; Maja Stojiljkovic; Anita Skakic; Kristel Klaassen; Sonja Pavlovic
Journal:  Endocrine       Date:  2021-03-14       Impact factor: 3.633

Review 7.  Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mirjana Kocova; Violeta Anastasovska; Henrik Falhammar
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

8.  Health problems of adolescent and adult patients with 21-hydroxylase deficiency.

Authors:  Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2018-10-30

Review 9.  The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency.

Authors:  Duarte Pignatelli; Berta L Carvalho; Aida Palmeiro; Alberto Barros; Susana G Guerreiro; Djuro Macut
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-04       Impact factor: 5.555

10.  No Evidence for Enhancement of Spatial Ability with Elevated Prenatal Androgen Exposure in Congenital Adrenal Hyperplasia: A Meta-Analysis.

Authors:  Marcia L Collaer; Melissa Hines
Journal:  Arch Sex Behav       Date:  2020-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.